BSL-2 LABORATORY DESIGN AND CONSTRUCTION BUSINESS PLAN
I. Executive Summary
Company Description
The company name is not provided. We are a U.S.-based specialized contractor entering the biotechnology infrastructure sector in 2026, delivering certified Biosafety Level 2 (BSL-2) laboratories. Our core offer is a single-source, turnkey solution that integrates biosafety expertise, architectural design, and specialized engineering to deliver ready-to-occupy BSL-2 facilities. One-liner: We deliver certified BSL-2 labs as a single contract, end-to-end.
We serve biotechnology, pharmaceutical, and academic customers, managing the entire project lifecycle to eliminate multi-vendor coordination risk. Our team is composed of certified professionals focused on de-risking laboratory construction through full project management, compliance assurance, and integrated technical design. Short-term goal: launch in 2026 and complete initial pilot projects. Long-term goal: scale nationwide and standardize modular, repeatable BSL-2 solutions. One-liner: We reduce execution and compliance risk for institutional lab builds.
Problem
Institutions building Biosafety Level 2 (BSL-2) laboratories face a persistent gap: standard general contractors lack the regulatory, biosafety, and specialized engineering expertise required for CDC and NIH-compliant lab delivery. This gap causes project delays, schedule slippage, increased remediation and rework costs, failed initial certifications, and interruptions to research programs and funding milestones.
One clear fact: current delivery models leave regulatory, technical, and coordination risks unmanaged, so institutions need a single-source, turnkey provider to de-risk BSL-2 lab construction.
Our firm, launching in 2026, is a U.S.-based specialized contractor combining biosafety certification, architectural design, and specialized engineering to close that gap for biotechnology, pharmaceutical, and academic clients by managing the full project lifecycle and eliminating multi-vendor coordination failures.
Solution
Construction of BSL-2 laboratories is complex, highly regulated, and often mishandled by general contractors, causing delays, compliance failures, and unsafe environments. We deliver turnkey BSL-2 lab design, build, and certification under a single contract to remove coordination gaps and reduce certification risk.
Our integrated team manages risk assessments, compliant architectural design, MEP/HVAC integration, and final validation, providing a single point of responsibility so clients receive fully operational, certified laboratories ready for immediate research use.
Mission Statement
Our mission is to deliver the highest level of expertise in designing and constructing Biosafety Level 2 laboratories that protect researchers and preserve scientific integrity. We commit to innovative, efficient, and fully compliant facilities while de-risking projects through a single-source responsibility model that simplifies delivery and accountability. We aim to be the trusted partner for biotechnology and pharmaceutical organizations, enabling them to focus on breakthrough research in safe, state-of-the-art environments.
Key Success Factors
We deliver compliant BSL-2 lab projects on time and under budget through a single-source model and recurring services.
-
In-house specialized expertise providing turnkey, single-source responsibility for projects.
-
Proprietary design templates and compliance checklists that drive 100% regulatory approval.
-
Established subcontractor and manufacturer relationships that control costs and shorten timelines.
-
High professional liability insurance offering risk coverage and client confidence for high-stakes projects.
-
Recurring maintenance and recertification contracts creating predictable, long-term revenue.
Financial Summary
The company projects strong growth with early breakeven and a clear path to cash-positive operations.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | $1,943,000 | $3,778,000 | $4,959,000 |
Projected EBITDA | $131,000 | $1,427,000 | $1,964,000 |
Expected ROI | IRR 10.44% / ROE 10.54% | IRR 10.44% / ROE 10.54% | IRR 10.44% / ROE 10.54% |
Financial requirements: initial capex of $249,500 and minimum cash buffer of $504,000; breakeven is forecast for Jul-26 with a 15-month payback.
The plan delivers predictable cash flow and an investor IRR of 10.44%.
Funding Requirements
We require a $504,000 launch fund to support a plan that targets $1,943,000 revenue in 2026 and $7,906,000 by 2030, reaches breakeven in July 2026 (7 months), grows EBITDA from $131,000 to $3,693,000 by year five, and delivers a 10.44% IRR, 10.54% ROE and a 15-month payback.
Categories | Amount, USD |
Office Infrastructure and Furniture | $45,000 |
High-Performance Engineering Workstations | $35,000 |
BIM and Project Management Server Setup | $22,000 |
Airflow Testing and Validation Equipment | $55,000 |
Specialized Field Safety Gear | $8,500 |
Company Vehicle for Site Visits | $42,000 |
Initial Proprietary Template Development | $30,000 |
Working capital | $254,500 |
Total funding required | $504,000 |